Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV, & COVID-19 and LIAISON PLEX Respiratory (RSP) Flex Assays in Symptomatic Patients in Australia

NCT06392451 is registered in ClinicalTrials.gov with DiaSorin Molecular LLC as lead sponsor.

NCT NCT06392451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV, & COVID-19 and LIAISON PLEX Respiratory (RSP) Flex Assays in Symptomatic Patients in Australia
Lead sponsor
DiaSorin Molecular LLC
Phase
Not applicable
Overall status
Unknown status
Start date
May 6, 2024
Completion date
October 31, 2024
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus, bordetella parapertussis infection, bordetella pertussis infection, respiratory, chlamydia pneumonia, coronavirus disease 2019, enterovirus, influenza a, influenza type b, mycoplasma pneumonia, para influenza, respiratory syncytial virus (rsv)